EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202

Kimberley S Mak, Molly Scannell Bryan, James J Dignam, William U Shipley, Yue Lin, Christopher A Peters, Elizabeth M Gore, Seth A Rosenthal, Kenneth L Zeitzer, David P D'Souza, Eric M Horwitz, Thomas M Pisansky und 11 weitere

European Urology Focus · 2024

DOI: 10.1016/j.euf.2024.01.008 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Urology Focus, 2024. Verfasst von Kimberley S Mak und 22 weiteren Autor:innen. Beteiligte Einrichtung: Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Electronic address: kimberley.mak@bmc.org. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Androgen Antagonists, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Androgen deprivation therapy (ADT) has been associated with coronary heart disease and myocardial infarction (MI) in prostate cancer patients, but controversy persists regarding its effects on cardiovascular mortality (CVM). OBJECTIVE: We assessed the long-term relationship between ADT and CVM in a prostate cancer randomized trial (NRG Oncology/Radiation Therapy Oncology Group 9202). DESIGN, SETTING, AND PARTICIPANTS: From 1992 to 1995, 1554 men with locally advanced prostate cancer (T2c-T4, prostate-specific antigen

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAndrogen AntagonistsCardiovascular DiseasesHumansMaleAgedMiddle AgedTime FactorsFollow-Up StudiesProportional Hazards Models

Stichwörter der Autor:innen

Androgen deprivation therapyCardiovascular mortalityHormonal therapyProstate cancerRadiation therapy

Substanzen

Androgen Antagonists

Autor:innen und Institutionen

  • Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Electronic address: kimberley.mak@bmc.org.
  • University of Illinois Cancer Center, Chicago, IL, USA.
  • University of Chicago, Chicago, IL, USA; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA.
  • Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
  • Northeast Radiation Oncology Center, Dunmore, PA, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Mak, K. S., Scannell Bryan, M., Dignam, J. J., Shipley, W. U., Lin, Y., Peters, C. A., Gore, E. M., Rosenthal, S. A., Zeitzer, K. L., D'Souza, D. P., Horwitz, E. M., Pisansky, T. M., Maier, J. M., Chafe, S. M., Robin, T. P., Roach, M., Tran, P. T., Souhami, L., Michalski, J. M., …, & Efstathiou, J. A. (2024). Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202. European Urology Focus. https://doi.org/10.1016/j.euf.2024.01.008

Vancouver

Mak KS, Scannell Bryan M, Dignam JJ, Shipley WU, Lin Y, Peters CA, et al. Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202. European Urology Focus. 2024. doi:10.1016/j.euf.2024.01.008

BibTeX
@article{Mak2024,
  author = {Mak, Kimberley S and Scannell Bryan, Molly and Dignam, James J and Shipley, William U and Lin, Yue and Peters, Christopher A and Gore, Elizabeth M and Rosenthal, Seth A and Zeitzer, Kenneth L and D'Souza, David P and Horwitz, Eric M and Pisansky, Thomas M and Maier, Jordan M and Chafe, Susan M and Robin, Tyler P and Roach, Mack and Tran, Phuoc T and Souhami, Luis and Michalski, Jeff M and Hartford, Alan C and Feng, Felix Y and Sandler, Howard M and Efstathiou, Jason A},
  title = {Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202},
  journal = {European Urology Focus},
  year = {2024},
  doi = {10.1016/j.euf.2024.01.008}
}
Kostenlos starten →